63 related articles for article (PubMed ID: 6401779)
1. The anticellular and protein-inducing activities of human gamma interferon preparations are mediated by the interferon.
Rubin BY; Bartal AH; Anderson SL; Millet SK; Hirshaut Y; Feit C
J Immunol; 1983 Mar; 130(3):1019-20. PubMed ID: 6401779
[No Abstract] [Full Text] [Related]
2. Monoclonal antibodies neutralizing the antiviral and the antiproliferative activities of human interferon gamma.
Kontsek P; Borecký L; Kontseková E; Sujanová Z; Novák M
Acta Virol; 1988 Jul; 32(4):334-8. PubMed ID: 2903638
[TBL] [Abstract][Full Text] [Related]
3. In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection.
Tanaka-Kataoka M; Kunikata T; Takayama S; Iwaki K; Ohashi K; Ikeda M; Kurimoto M
Cytokine; 1999 Aug; 11(8):593-9. PubMed ID: 10433806
[TBL] [Abstract][Full Text] [Related]
4. The enhancement of human tumor necrosis factor-alpha antiviral activity in vivo by monoclonal and specific polyclonal antibodies.
Lidbury BA; Aston R; Ramshaw IA; Cowden WB; Rathjen DA
Lymphokine Cytokine Res; 1993 Apr; 12(2):69-74. PubMed ID: 8324079
[TBL] [Abstract][Full Text] [Related]
5. Human interferon-gamma has three domains associated with its antiviral function: a neutralizing epitope typing scheme for human interferon-gamma.
Kwok AY; Zu X; Yang C; Alfa MJ; Jay FT
Immunology; 1993 May; 79(1):131-7. PubMed ID: 7685313
[TBL] [Abstract][Full Text] [Related]
6. Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge.
Pulford DJ; Gates A; Bridge SH; Robinson JH; Ulaeto D
Vaccine; 2004 Sep; 22(25-26):3358-66. PubMed ID: 15308360
[TBL] [Abstract][Full Text] [Related]
7. Prevention of lethal respiratory vaccinia infections in mice with interferon-alpha and interferon-gamma.
Liu G; Zhai Q; Schaffner DJ; Wu A; Yohannes A; Robinson TM; Maland M; Wells J; Voss TG; Bailey C; Alibek K
FEMS Immunol Med Microbiol; 2004 Apr; 40(3):201-6. PubMed ID: 15039095
[TBL] [Abstract][Full Text] [Related]
8. The role for host-immune factors in the in vivo antiviral effects of tumour necrosis factor.
Lidbury BA; Ramshaw IA; Sambhi SK
Cytokine; 1995 Feb; 7(2):157-64. PubMed ID: 7780035
[TBL] [Abstract][Full Text] [Related]
9. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).
Smith PM; Wolcott RM; Chervenak R; Jennings SR
Virology; 1994 Jul; 202(1):76-88. PubMed ID: 7912023
[TBL] [Abstract][Full Text] [Related]
10. A monoclonal antibody to the NH2-terminal segment of human IFN-gamma selectively interferes with the antiproliferative activity of the lymphokine.
Caruso A; Tiberio L; De Rango C; Bonfanti C; Flamminio G; Gribaudo G; Monti E; Viani E; Manca N; Garotta G
J Immunol; 1993 Feb; 150(3):1029-35. PubMed ID: 8423329
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to human alpha-interferon and their use for affinity chromatography.
Novick D; Eshhar Z; Rubinstein M
J Immunol; 1982 Nov; 129(5):2244-7. PubMed ID: 7119444
[TBL] [Abstract][Full Text] [Related]
12. Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins.
Mossman K; Upton C; Buller RM; McFadden G
Virology; 1995 Apr; 208(2):762-9. PubMed ID: 7747448
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of two subtypes of human leukocyte interferon (IFN-alpha) by monoclonal antibodies.
Imai M; Sano T; Yanase Y; Miyamoto K; Yonehara S; Mori H; Honda T; Fukuda S; Nakamura T; Miyakawa Y; Mayumi M
J Immunol; 1982 Jun; 128(6):2824-5. PubMed ID: 6176655
[No Abstract] [Full Text] [Related]
14. Structural immuno-analysis of human and porcine interferon gamma: identification of shared antigenic domain.
Kontsek P; Martens E; Vandenbroeck K; Kontseková E; Waschütza G; Sareneva T; Billiau A
Cytokine; 1997 Aug; 9(8):550-5. PubMed ID: 9245481
[TBL] [Abstract][Full Text] [Related]
15. [Preparation and characterization of monoclonal antibodies against chicken interferon-gamma].
Dai H; Jiao XA; Pan ZM; Huang JL; Hu MZ; Tang W; Liu XF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):510-2. PubMed ID: 16806019
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor immune response induced by the fractions derived from OK-432, a streptococcal preparation, by using a monoclonal antibody TS-2 that neutralizes the interferon-gamma-inducing activity of OK-432: comparison between the TS-2-binding and TS-2-unbinding fraction.
Oshikawa T; Okamoto M; Ohe G; Furuichi S; Nishikawa H; Uddin Ahmed S; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
Int Immunopharmacol; 2003 May; 3(5):643-55. PubMed ID: 12757734
[TBL] [Abstract][Full Text] [Related]
17. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
J Gene Med; 2009 Jan; 11(1):57-65. PubMed ID: 19006097
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract.
Milligan GN; Bernstein DI
Virology; 1997 Mar; 229(1):259-68. PubMed ID: 9123869
[TBL] [Abstract][Full Text] [Related]
19. Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost.
Shinoda K; Xin KQ; Kojima Y; Saha S; Okuda K; Okuda K
Clin Immunol; 2006 Apr; 119(1):32-7. PubMed ID: 16458074
[TBL] [Abstract][Full Text] [Related]
20. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
